Home
Guidelines
Pathogens
Antimicrobials
Medium
NA
1g IV q24h
Targeted therapy of ESBL infections and other resistant gram negative infections
Empiric therapy when broad spectrum of carbapenems is desired without the need for anti-pseudomonal activity
Immediate and delayed-type allergy
GI disturbance
Cytopenias, eosinophilia, positive Coombs
Liver enzyme abnormalities
Seizure risk lower than other carbapenems
At PHC, restricted to outpatient or ambulatory setting with ID approval
Antimicrobial class: Carbapenem
Pregnancy category: B
Average serum half life: 4.0
Biliary penetration: Moderate
Lung penetration: Therapeutic
Urine penetration: Therapeutic